Cargando…
Novel ACE2 fusion protein with adapting activity against SARS-CoV-2 variants in vitro
Despite the successful development of vaccines and neutralizing antibodies to limit the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerging variants prolong the pandemic and emphasize the persistent need to develop effective antiviral treatment regimens. Recombinant anti...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030959/ https://www.ncbi.nlm.nih.gov/pubmed/36969164 http://dx.doi.org/10.3389/fimmu.2023.1112505 |